These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7944950)

  • 1. Role of macrophages, interferon gamma and procoagulant activity in the resistance of genetic heterogeneous mouse populations to mouse hepatitis virus infection.
    Vassão RC; Mello IG; Pereira CA
    Arch Virol; 1994; 137(3-4):277-88. PubMed ID: 7944950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A genetic analysis of macrophage activation and specific antibodies in relation to the resistance of heterogeneous mouse populations to MHV3 infection.
    Vassão RC; Sant' Anna OA; Pereira CA
    Arch Virol; 1994; 139(3-4):417-25. PubMed ID: 7832646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific T-cell response correlates with resistance of genetic heterogeneous mouse populations to mouse hepatitis virus 3 infection.
    Vassão RC; Cabrera WH; Ibanez OC; Pereira CA
    Arch Virol; 1995; 140(7):1235-45. PubMed ID: 7646354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of Bgp1(a) viral receptor by interferon-gamma is related to the antiviral state and resistance to mouse hepatitis virus 3 infection.
    Vassão RC; de Franco MT; Hartz D; Modolell M; Sippel AE; Pereira CA
    Virology; 2000 Sep; 274(2):278-83. PubMed ID: 10964771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-MHV3 state induced by IFN gamma in macrophages is not related to arginine metabolism.
    Pereira CA; Soler G; Modolell M
    Arch Virol; 1997; 142(10):2001-10. PubMed ID: 9413508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A major role of macrophage activation by interferon-gamma during mouse hepatitis virus type 3 infection. I. Genetically dependent resistance.
    Lucchiari MA; Pereira CA
    Immunobiology; 1989 Nov; 180(1):12-22. PubMed ID: 2560461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance of genetically selected mice to MHV3 infection is not dependent on the H2O2 release by macrophages.
    Vassão R; Russo M; Marcondes MC; Pereira CA
    Microb Pathog; 1993 Mar; 14(3):169-76. PubMed ID: 8391622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TNF alpha, IL-1 and O2- release by macrophages do not correlate with the anti-mouse hepatitis virus 3 effect induced by interferon gamma.
    Lucchiari MA; Modolell M; Vassão RC; Pereira CA
    Microb Pathog; 1993 Dec; 15(6):447-54. PubMed ID: 8007817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired immunity of A/J mice to mouse hepatitis virus 3 infection: dependence on interferon-gamma synthesis and macrophage sensitivity to interferon-gamma.
    Lucchiari MA; Martin JP; Modolell M; Pereira CA
    J Gen Virol; 1991 Jun; 72 ( Pt 6)():1317-22. PubMed ID: 1646275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha/Beta Interferon (IFN-α/β) Signaling in Astrocytes Mediates Protection against Viral Encephalomyelitis and Regulates IFN-γ-Dependent Responses.
    Hwang M; Bergmann CC
    J Virol; 2018 May; 92(10):. PubMed ID: 29491163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virus specificity of the antiviral state induced by IFN gamma correlates with resistance to MHV 3 infection.
    Mello IG; Vassão RC; Pereira CA
    Arch Virol; 1993; 132(3-4):281-9. PubMed ID: 7691047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mouse hepatitis virus 3 binding to macrophages correlates with resistance to experimental infection.
    Pereira CA; Moreira C; Tsuhako MH; de Franco MT
    Scand J Immunol; 2005 Jul; 62 Suppl 1(Suppl 1):95-9. PubMed ID: 15953191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arginine metabolism during macrophage autocrine activation and infection with mouse hepatitis virus 3.
    Moreira C; Tsuhako MH; de Franco MT; Modolell M; Pereira CA
    Immunobiology; 2004; 209(8):585-98. PubMed ID: 15638127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody responsiveness during immunization and challenge of genetically modified antibody responder mice with murine hepatitis virus 3.
    Vassão RC; Consales CA; Sant'Anna OA; Pereira CA
    Immunobiology; 2003; 207(4):275-83. PubMed ID: 12952350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Murine cytomegalovirus infection inhibits IFN gamma-induced MHC class II expression on macrophages: the role of type I interferon.
    Heise MT; Pollock JL; O'Guin A; Barkon ML; Bormley S; Virgin HW
    Virology; 1998 Feb; 241(2):331-44. PubMed ID: 9499808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A major role of macrophage activation by interferon-gamma during mouse hepatitis virus type 3 infection. II. Age-dependent resistance.
    Lucchiari MA; Pereira CA
    Immunobiology; 1990 Aug; 181(1):31-9. PubMed ID: 2177034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to murine hepatitis virus strain 3 is dependent on production of nitric oxide.
    Pope M; Marsden PA; Cole E; Sloan S; Fung LS; Ning Q; Ding JW; Leibowitz JL; Phillips MJ; Levy GA
    J Virol; 1998 Sep; 72(9):7084-90. PubMed ID: 9696801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Murine viral hepatitis involves NK cell depletion associated with virus-induced apoptosis.
    Lehoux M; Jacques A; Lusignan S; Lamontagne L
    Clin Exp Immunol; 2004 Jul; 137(1):41-51. PubMed ID: 15196242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of resistance to murine hepatitis virus strain 3 infection after treatment with corticosteroids is associated with induction of macrophage procoagulant activity.
    Fingerote RJ; Abecassis M; Phillips MJ; Rao YS; Cole EH; Leibowitz J; Levy GA
    J Virol; 1996 Jul; 70(7):4275-82. PubMed ID: 8676449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential induction of antiviral effects against West Nile virus in primary mouse macrophages derived from flavivirus-susceptible and congenic resistant mice by alpha/beta interferon and poly(I-C).
    Pantelic L; Sivakumaran H; Urosevic N
    J Virol; 2005 Feb; 79(3):1753-64. PubMed ID: 15650200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.